Publications database

This update from the EU Early Warning System overviews the NPS situation in Europe in 2020-2021 and highlights emerging threats to support early warning, preparedness planning and response measures. In addition, it...

Take a journey through some of the key events over the last 25 years of monitoring new psychoactive substances in Europe.

Risk assessment is the second step in the three-step legal framework designed to allow the European Union (EU) to rapidly detect, assess, and respond to health and social threats caused by new...

This publication presents the data and findings of the risk assessment on 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC), carried out by the extended Scientific Committee of the EMCDDA on 19 November 2021. On the basis...

This publication presents the data and findings of the risk assessment on 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2021. On the basis...

3-CMC is a synthetic cathinone monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2014. Based on potential public health risks, an initial report...

3-MMC is a synthetic cathinone monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2012. Based on potential public health risks, an initial report...

This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the the EU Early Warning System. The aim of this report is to...

This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System. The aims of this report are to strengthen...

This publication presents the data and findings of the risk assessment on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA), carried out by the extended Scientific Committee of the EMCDDA on 9 December 2020. On the basis...